Genpharmasec Board Approves AGM, Director Reappointment

The Board considered and approved the following items:

Fixed the 34th Annual General Meeting (AGM) for Tuesday, 29th September, 2026 at 11:00 A.M. through Video Conferencing (VC) or Other Audio Visual Means (OAVM). Approved the Draft Notice & Calendar of Events for the AGM.

Fixed the cut-off date as Tuesday, 22nd September, 2026 to determine entitlement of voting rights for e-voting. Set e-voting commencement on Saturday, 26th September, 2026 at 9:00 a.m. IST and closing on Monday, 28th September, 2026 at 5:00 p.m. IST.

Considered and approved the Director's Report for the financial year ended 31st March, 2026.

Approved closure of the Share Transfer Book and Member's Registers from Wednesday, 23rd September, 2026 to Tuesday, 29th September, 2026 (both days inclusive) for the AGM, in compliance with Section 91 of Companies Act, 2013 and Regulation 42 of listing regulations.

Approved appointment of M/S. Jaymin Modi & Co., Practicing Company Secretaries as Scrutinizer for the 34th AGM to scrutinize e-voting and remote e-voting process.

Approved re-appointment of Mr. Sohan Chaturvedi (DIN: 09629728) as Whole Time Director of the Company, subject to shareholder approval.

Approved advances/loans/guarantees/security under Section 185 of Companies Act, 2013, subject to shareholder approval.

Director Re-appointment Information:

Name: Mr. Sohan Chaturvedi (DIN: 09629728)
Reason for change: Re-Appointment
Effective Date: 26th April, 2027
Term: Re-Appointment as Whole Time Director for 3 years effective 26th April, 2027, subject to shareholder approval
Brief Profile: Bachelor of Commerce and Master of Commerce from Agra University, with 17 years of experience and expertise in finance and accounting
Disclosure of relationships: None
No debarment from holding office of Director by virtue of any SEBI Order or other authority